You are here

  • Home
  • Archive
  • Volume 78, Issue 9
  • Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria

Article Text

Article menu
Download PDFPDF
Letter
Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria

https://doi.org/10.1136/annrheumdis-2019-215031

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Handling editor Josef S Smolen

    • Contributors MG: study design, data management, analysis, interpretation, verification, writing. MJGdY: study design, analysis, verification, interpretation. IA: data management, interpretation. AMB-G: data management, interpretation. IR-F: data management, interpretation, writing. EL: interpretation, writing. LC: study design, verification, interpretation, writing.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Ethics approval Ethical approval for this study was obtained from the ethical committee of the Hospital Universitario de Gran Canaria Dr. Negrín (code 2018-222-1).

    • Provenance and peer review Not commissioned; externally peer reviewed.